GlassScriptPhysician profile
Timothy R Weimer
NPI 1447292495
$3,008.95
in general payments reported to CMS, 2019-2025
28 companies · $678 in 2025
The $678 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,774 · 2022: $42.38 · 2023: $294 · 2024: $221 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.26 |
| Education | $228.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $1,191.78 | 2021 | |
| Janssen Biotech, INC. | $277.63 | 2021-2025 | Erleada |
| Astellas Pharma US INC | $218.84 | 2021-2025 | Xtandi |
| Astrazeneca Pharmaceuticals LP | $138.88 | 2022-2025 | Lynparza |
| Progenics Pharmaceuticals, INC. | $124.63 | 2024 | |
| Antares Pharma, INC. | $122.48 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Coloplast Corp | $107.72 | 2021 | |
| Axonics, INC. | $105.12 | 2021 | |
| Dentsply Ih Ab | $99.39 | 2024-2025 | Lofric |
| Pfizer INC. | $98.17 | 2021-2025 | |
| Clarus Therapeutics INC. | $86.68 | 2021 | |
| Seagen INC. | $78.99 | 2025 | |
| Boston Scientific Corporation | $46.53 | 2025 | Ams 700 |
| Medtronic, INC. | $44.34 | 2022-2023 | Interstim |
| Myovant Sciences INC. | $42.30 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $24.89 | 2021 | |
| Laborie Medical Technologies Corp. | $24.69 | 2024 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Avyxa Pharma, LLC | $21.95 | 2025 | |
| Bioprotect Medical, INC. | $21.92 | 2025 | Bioprotect Balloon Implant System |
| Tempus Ai, INC | $21.76 | 2025 | Xt Cdx |
| Teleflex LLC | $17.63 | 2024 | Solesta |
| Dendreon Pharmaceuticals LLC | $16.76 | 2025 | Provenge |
| Novartis Pharmaceuticals Corporation | $15.60 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $14.00 | 2025 | Bard Urinary Drainage Bag |
| Urovant Sciences INC | $13.82 | 2021 | |
| Abbvie INC. | $12.78 | 2021 | |
| Myriad Genetic Laboratories, INC. | $11.29 | 2021 | |
| Janssen Scientific Affairs, LLC | $8.38 | 2025 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Weimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.